CVD RISK PREDICTION: PAST, PRESENT & FUTURE Ramesh Singh Veriah Cardiology Unit University Malaya Medical Centre (UMMC)
AIMS • History • What is risk? • How does risk relate to the management of cardiovascular disease (CVD)? • Calculating CVD risk. • How can we communicate risk to patients?
Introduction • CVD initially thought of as a natural consequence of aging. • With time life‐style factors and biochemical as well as genetic factors were identified.
Seven Countries Study • 1958 – 1970, men ages 40‐59 from 7 countries • Clearly demonstrated that CVD rates varied around the world and is influenced by environmental factors. • Migration factors appeared to have a strong influence.
Framingham Heart Study 1961 • Earliest landmark study. • Showed that hypertension, high cholesterol and smoking increased CV risk. • Development of CVD involves a number of risk factors.
Cardiovascular Disease is a Common Complex Disease Elevated Blood Pressure
Adverse Lipid Profile
Diabetes
Family History Cardiovascular Disease
Sedentary Lifestyle
Obesity
Smoking
Nutrition
"At least hundreds of genes are involved in cardiovascular disease” - Lusis AJ, 2000
“You can only predict things after they have happened”
Eugéne Ionesco 1912‐1994
What is risk? Risk is the likelihood of being harmed in some way How we define and understand risk depends on – – – – –
emotional factors rather than hard facts our instinctive bias if we understand the difference between risks and hazards based on evidence common sense
Harm is not often due to a single cause so it becomes harder to define what a risk is When we try to avoid a risk, we can change some part of the situation that potentially results in exposure to a different risk
Risk Factor Assessment • Rarely occur in isolation. • Rather CVD is a convergence of a number of risk factors thus global assessment is needed. • Combine risk factors with disease markers can prove to be beneficial • Important to identify the modifiable risk factors as it is a potential target for intervention. • Which risk factor is an important predictor, assess it at minimal cost and easiest way.
CV Risk Prediction: Application • Population ‐ planning for public health messages/forums • Individual ‐ target more intensive programs that are also personalized to maximize the prevention of disease
A ‘Perfect’ Risk Factor • • • •
Prevalent in the population Can be easily and safely measured Good predictive value Inexpensive to measure
Risk Scoring • Many risk factors are correlated with one another. • When conducting an initial screen only a handful of easily measured risk factors are needed to measure the individuals overall cardiac risk. • Low risk or high risk (clearly scored) individuals will not need any further evaluation of additional risk factors as this will only add to cost and not yield further information. • It is the intermediate risk individuals that will warrant further stratification. • Allows cost‐effective targeting of interventions.
CRUDE ASSESSMENT Risk of a Second Vascular Event Increased risk vs general population (%) Original event
Myocardial infarction
Stroke
Myocardial infarction
5–7 x greater risk1
3–4 x greater risk2
(includes death)
(includes TIA)
2–3 x greater risk2
9 x greater risk3
Stroke
(includes angina and sudden death*) Peripheral arterial disease 4 x greater risk4 (includes only fatal MI and other CHD death†)
2–3 x greater risk3 (includes TIA)
*Sudden death defined as death documented within 1 hour and attributed to coronary heart disease (CHD) † Includes only fatal MI and other CHD death; does not include non-fatal MI 1. Adult Treatment Panel II. Circulation 1994; 89:1333–63. 2. Kannel WB. J Cardiovasc Risk 1994; 1: 333–9. 3. Wilterdink JI, Easton JD. Arch Neurol1992; 49: 857–63. 4. Criqui MH et al. N Engl J Med 1992; 326: 381–6.
High Risk Group • Diabetics • Chronic renal failure • These groups warrant aggressive preventive interventions.
Risk Prediction Scores • • • • • •
Simple and reliable way. Low cost. Framingham Risk Scoring HeartScore (ESC) PROCAM Algorithm New Zealand Risk Scoring
Improving Risk Scoring • • • • •
Calcium scoring Multi‐slice CT Echocardiography Cardiac catheterization C‐reactive protein (CRP)
Women’s Health Study • Addition of family history, HBA1c if diabetic and CRP can further reclassify women at intermediate risk to either low or high risk.
LOWERING RISK • 3 complementary approaches ‐ therapeutic interventions for secondary prevention in patients with known CVD ‐ identification and targeting of high‐risk individuals for primary prevention through mass screening or case finding ‐ general recommendations disseminated throughout the population
Framingham Data Individuals who can reduce and minimize risk factor burden before age of 50 will substantially lower their life‐time risk of developing CVD
Communicating risk to patients • It is difficult to communicate risk and uncertainty • When discussing cardiovascular disease (CVD) risk with people, show them the risk prediction charts (and calculator) to help them understand their estimated risk of experiencing a cardiovascular event within the next 10 years • It is usually more helpful to discuss total CVD risk rather than individual risks for CHD, stroke or other events • Individuals may have differing thresholds of risk before considering drug treatment to lower risk and this may be associated with social class
Communicating risk to patients • If people want to know the benefits and risks of investigations and treatments then we have to be able to communicate them effectively • The way in which health professionals communicate risk affects patients’ perception of that risk • Patients should be provided with a balanced and fair assessment of the pros and cons of the various options, based on well‐founded data • Use of simple visual aids and everyday analogies can help to increase understanding and ensure that consent is properly informed